Future Market Insights suggests that within the glycine landscape, the simultaneous exit of a major USA producer and strategic restructuring of European amino acid portfolios is tightening the Western supply base and concentrating production capacity in China. FMI analysts identify the supply chain vulnerability created by domestic capacity closures as the central pivot point, effectively increasing procurement risk for pharmaceutical and food-grade glycine buyers outside China.